Treating Rare Driver Mutations in NSCLC: EGFR Exon 20 Insertions
During a Case-Based Roundtable® event, Misako Nagasaka, MD, discussed treatment for a patient with non–small cell lung cancer and an EGFR exon 20 insertion.
During a Case-Based Roundtable® event, Misako Nagasaka, MD, discussed treatment for a patient with non–small cell lung cancer and an EGFR exon 20 insertion.
Petros Grivas, MD, PhD, discusses the significance of the phase 3 JAVELIN Bladder 100, EV-302, and CheckMate 901 trials in urothelial cancer.
The National Heart, Lung and Blood Institute (NHLBI), along with four other NIH institutes, is building a new population study from the ground up and…
More than half of 35 million cases are preventable
Due to federal budget constraints, the National Cancer Institute faces significant risk, impacting cancer research funding amid crucial breakthroughs.
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
R. Lor Randall, MD, FACS, detailed research into the relationship between guideline-concordant care and survival outcomes in patients with osteosarcoma in California.
A dual-recombinase reversible knock-in/knock-out mouse model of Jak2V617F validates the absolute requirement of Jak2V617F in sustaining myeloproliferative neoplasms and provides rationale for the clinical development…
Background: Undifferentiated pleomorphic sarcomas (UPSs) are amongst the most common subtypes of soft-tissue sarcomas. Few real-world data on the use of immune checkpoint blockade (ICB)…
Register for ASTRO’s radiopharmaceutical webinar series.